China's first independent research and development anti-cancer Chinese medicine will enter the international market

        Report from our correspondent held by holley dalian jingang pharmaceutical co., LTD. "twelfth five-year" national drug discovery major projects "lam incense ene liposome injection microbial detection and impurity control technology research" technology breakthrough. The project method was developed to establish Chinese medicine microbial detection platform and fingerprint identification technology platform, means lam incense ene liposomes series targeted anti-cancer natural medicine quality standard is expected to reach the highest international standards such as the United States, the European Union.

        National authoritative medical verification show that based on conventional radiation and chemotherapy scheme with golden port lam incense ene to treat lung cancer, esophageal cancer, gastric cancer, liver cancer, leukemia, brain tumor, breast cancer and gynecological tumor.

        Based on the patent technology, dalian holley jingang established China's first through the GMP certification of liposome targeting agents specialized production lines, the first independent research and development of anticancer Chinese traditional medicine will also be to enter the international market. (Li Huiyu)

        Proceedings of the People's Republic of China (the 2013-07-03 version 8)

The original link: http://news.sciencenet.cn/sbhtmlnews/2013/7/274874.shtm

(this site editor Wang Zhong one)